RCM
MYGN icon

RNC Capital Management’s Myriad Genetics MYGN Stock Holding History

RNC Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-76,813
Closed -$2.35M – 145
2016
Q2 		$2.35M Sell
76,813
-150
-0.2% -$5.21K 0.22% 64
2016
Q1 		$2.88M Sell
76,963
-1,575
-2% -$59.3K 0.28% 60
2015
Q4 		$3.39M Sell
78,538
-5,140
-6% -$217K 0.34% 60
2015
Q3 		$3.14M Buy
83,678
+3,435
+4% +$122K 0.3% 54
2015
Q2 		$2.73M Sell
80,243
-875
-1% -$29.8K 0.23% 57
2015
Q1 		$2.87M Buy
81,118
+1,478
+2% +$52.9K 0.24% 55
2014
Q4 		$2.71M Buy
79,640
+5,822
+8% +$207K 0.22% 58
2014
Q3 		$2.85M Sell
73,818
-2,825
-4% -$105K 0.23% 59
2014
Q2 		$2.98M Buy
76,643
+675
+0.9% +$25.1K 0.24% 59
2014
Q1 		$2.6M Buy
75,968
+24,000
+46% +$744K 0.23% 61
2013
Q4 		$1.09M Sell
51,968
-19,432
-27% -$491K 0.1% 70
2013
Q3 		$1.68M Buy
71,400
+3,925
+6% +$112K 0.17% 61
2013
Q2 		$1.81M Buy
+67,475
New +$1.96M 0.19% 62

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RNC Capital Management's MYGN Position: Q3 2016 in Review

RNC Capital Management sold out of Myriad Genetics (MYGN) in Q3 2016, closing a stake of 76,813 shares — an estimated $2.35M sold.

RNC Capital Management first reported a position in MYGN in Q2 2013 and held it in 13 quarters. The position peaked at $3.39M in Q4 2015. 223 funds tracked by Wall St. Rank hold MYGN as of Q3 2016.

  • RNC Capital Management reported no remaining Myriad Genetics position as of Q3 2016 after selling out during the quarter.
  • RNC Capital Management sold 76,813 Myriad Genetics shares in Q3 2016, an estimated $2.35M.
  • RNC Capital Management first reported a position in Myriad Genetics in Q2 2013 and held it in 13 quarters.
  • RNC Capital Management's Myriad Genetics position peaked at $3.39M in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2016.

Based on RNC Capital Management's 13F filing for Q3 2016, filed 19 Oct 2016.